Xeris Biopharma Holdings, Inc. (2B30.F)
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
7.19-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+64.1%
The outlook
Xeris Biopharma Holdings, Inc. currently reads as bullish based on above its 50- & 200-day averages, 69% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range69% of the way from its 52-week low to high
Market cap
$1.24B
52-wk high
8.48
52-wk low
4.38
50-day avg
6.33
200-day avg
5.94
Trailing P/E
119.9